Pakistan, China propaganda fails as this neighbouring country of India is set to deploy biggest Rafale fighter jet fleet; deal is.., it is...
Indonesia is poised to formally finalize an expanded defense deal with France, which will see it acquire 24 more Rafale multirole fighter jets. This is expected to change the strategic power balance in Southeast Asia over the next decade.
The significance of this deal is further bolstered by the fact that, despite extensive propaganda by China and Pakistan against the Rafale, Indonesia has placed its confidence in the jet, underscoring the aircraft's importance in reference to defense planning in the region. According to defense sources quoted by the French media outlet La Tribune, 'Indonesia is no longer seeking a dozen Rafales, but rather 24 fighter jets manufactured by Dassault Aviation.' Furthermore, it added that the contract might be signed during the Indonesian President Prabowo Subianto's visit to Paris. It is reported that the Indonesian President will be France's guest of honor on July 14, on the Bastille Day celebrations.
As per Eurasian Times, several other key defence contracts are likely to be signed during the Paris visit. This includes a deal for two Scorpène submarines, up to 36 Caesar self-propelled guns, and light frigates.
Indonesia is an important defense partner for France in Southeast Asia. Historically dependent on Russian military equipment, Jakarta has been seeking to diversify its defense suppliers and, in this process, is increasingly looking to France. The defense relationship between Indonesia and France formally began in 2022 when Indonesia signed a contract worth US$8.1 billion to purchase 42 Rafale jets.
Subsequently, Jakarta announced plans to buy 13 long-range air surveillance radars from France's Thales in 2023, then purchase two 'Scorpene' submarines from the French state shipbuilder Naval Group in 2024. This was also the start of a new chapter in Indonesia's defense procurement, showing a clear preference for French equipment.
Indonesia has not yet received its first Rafale fighter aircraft. Mohamad Tonny Harjono, the Chief of Staff of the Indonesian Air Force, said in February that the six aircraft would arrive in Indonesia during the first half of 2026. The contract will be delivered in three phases of acquisition of 6, 18, and 18.
If the purchase of 24 more Rafales is completed, Indonesia would become the first foreign customer for the French-made fighter since the May India-Pakistan conflict, during which Pakistan claimed to shoot down five Indian jets with its Chinese-made J-10CE and JF-17 fighters specifically three Rafales. To add nuance to the story, it is also worth noting that while the Indian Air Force (IAF) also acknowledged combat losses to Pakistan in the brief four-day war, it has, however, not published the number of aircraft lost or any information regarding the type of aircraft lost.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 minutes ago
- Time of India
Indian military will have to be prepared to respond to any acts of violence by Pakistan: CDS
General Anil Chauhan has said that the Indian military must prepare for potential violence from Pakistan. This includes both state and non-state actors. He highlighted the need to challenge Pakistan's full-spectrum deterrence doctrine. Terrorists cannot hide within Pakistan's borders. The military should be ready to strike fixed and mobile targets at long ranges. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Indian military will have to be prepared to respond to "any acts of violence by Pakistan", both by state and non-state actors, and those in the armed forces should understand this "new norm", Chief of Defence Staff Gen Anil Chauhan said on a keynote address at an event here, the CDS said there was a need to challenge the Pakistani doctrine of " full-spectrum deterrence ", asserting that terrorists cannot hide in any part of at the inaugural edition of the Annual Trident Lecture Series, he reiterated that military preparedness has to be of a very high order, round-the-clock and 365 days a also underlined that there is a very little distinction between war and peace, and added that they are seemingly merging."We need to create more space for conventional operations, between the unconventional and nuclear domains. And, we need to challenge the Pakistani doctrine of full-spectrum deterrence, which talks about deterrence at the lowest level to the highest," the CDS further said that terrorists cannot hide anywhere in the territory of Chauhan also emphasised that the Indian military should have the capabilities to hit both fixed and mobile targets at extreme ranges."We have to be prepared to respond to any acts of violence by Pakistan, both state and non-state (actors), and that's the first norm, we must understand this. That's the new norm for all of us," he CDS said another military norm is a greater reliance on the nuclear doctrine, which forms a bedrock for conventional operations. He added that another norm would be maintaining a technological edge over event was organised by the think tank Centre for Joint Warfare Studies (CENJOWS) at Manekshaw Centre in Delhi Cantonment to mark its foundation CDS underscored the importance of technological convergence and integrated operations to ensure national security in today's Chauhan emphasised the need to adapt swiftly to disruptive technologies, rethink legacy structures and prioritise synergy across the three services to tackle the challenges emanating from the constantly evolving nature of Headquarters Integrated Defence Staff (HQ IDS), in a post on X, also shared he broader contours of the talk."CDS urged military practitioners to embrace a proactive, indigenous and adaptive vision anchored in strategic foresight, technological autonomy and doctrinal agility. He articulated the need to craft an uniquely 'Indian way of War-fighting' with the fusion of kinetic and non-kinetic capabilities, combined with bold doctrinal shift towards integrated & multi-domain operations," the post CDS emphasised blending "conventional and unconventional tools of warfare" to achieve decisive outcomes. This forward-looking approach, he noted, would be vital to navigate the complexities of future conflicts and ensure enduring national security, the HQ IDS said.A key highlight of the event was the release of the first 'General Bipin Rawat Paper' on 'Manned-Unmanned Teaming (MUM-T)' -- a tribute to India's first CDS and his vision in transforming joint war-fighting August 2025 issue of 'Synergy', CENJOWS's flagship journal, was also launched, featuring incisive analyses on emerging global and regional security trends. PTI
&w=3840&q=100)
Business Standard
2 minutes ago
- Business Standard
Indian military must stay ready to counter all Pakistani threats: CDS
Indian military will have to be prepared to respond to "any acts of violence by Pakistan", both by state and non-state actors, and those in the armed forces should understand this "new norm", Chief of Defence Staff Gen Chauhan said on Tuesday. Delivering a keynote address at an event here, the CDS said there was a need to challenge the Pakistani doctrine of "full-spectrum deterrence", asserting that terrorists cannot hide in any part of Pakistan. Speaking at the inaugural edition of the Annual Trident Lecture Series, he reiterated that military preparedness has to be of a very high order, round-the-clock and 365 days a year. He also underlined that there is a very little distinction between war and peace, and added that they are seemingly merging. "We need to create more space for conventional operations, between the unconventional and nuclear domains. And, we need to challenge the Pakistani doctrine of full-spectrum deterrence, which talks about deterrence at the lowest level to the highest," the CDS said. He further said that terrorists cannot hide anywhere in the territory of Pakistan. Gen Chauhan also emphasised that the Indian military should have the capabilities to hit both fixed and mobile targets at extreme ranges. "We have to be prepared to respond to any acts of violence by Pakistan, both state and non-state (actors), and that's the first norm, we must understand this. That's the new norm for all of us," he said. The CDS said another military norm is a greater reliance on the nuclear doctrine, which forms a bedrock for conventional operations. He added that another norm would be maintaining a technological edge over adversaries. The event was organised by the think tank Centre for Joint Warfare Studies (CENJOWS) at Manekshaw Centre in Delhi Cantonment to mark its foundation day. The CDS underscored the importance of technological convergence and integrated operations to ensure national security in today's times. Gen Chauhan emphasised the need to adapt swiftly to disruptive technologies, rethink legacy structures and prioritise synergy across the three services to tackle the challenges emanating from the constantly evolving nature of warfare. The Headquarters Integrated Defence Staff (HQ IDS), in a post on X, also shared he broader contours of the talk. "CDS urged military practitioners to embrace a proactive, indigenous and adaptive vision anchored in strategic foresight, technological autonomy and doctrinal agility. He articulated the need to craft an uniquely 'Indian way of War-fighting' with the fusion of kinetic and non-kinetic capabilities, combined with bold doctrinal shift towards integrated & multi-domain operations," the post said. The CDS emphasised blending "conventional and unconventional tools of warfare" to achieve decisive outcomes. This forward-looking approach, he noted, would be vital to navigate the complexities of future conflicts and ensure enduring national security, the HQ IDS said. A key highlight of the event was the release of the first 'General Bipin Rawat Paper' on 'Manned-Unmanned Teaming (MUM-T)' -- a tribute to India's first CDS and his vision in transforming joint war-fighting philosophy. The August 2025 issue of 'Synergy', CENJOWS's flagship journal, was also launched, featuring incisive analyses on emerging global and regional security trends.
&w=3840&q=100)
Business Standard
2 minutes ago
- Business Standard
Gland Pharma Q1 profit jumps 50% on core growth, Cenexi turnaround
Hyderabad-based Gland Pharma reported a 50 per cent increase in its consolidated net profit year-on-year (Y-o-Y), reaching ₹215 crore for the first quarter of the financial year (Q1FY26). Revenue from operations rose 7 per cent Y-o-Y to ₹1,505 crore. The growth was driven by robust performance in its core business and a successful turnaround at Cenexi, a French pharmaceutical contract development and manufacturing organisation (CDMO) specialising in sterile injectable and lyophilised drug products, which Gland Pharma acquired in 2023. Sequentially, the company's net profit rose by 15 per cent, and revenue increased by 6 per cent. 'We're off to a positive start this year with growth in revenue and a jump in profitability. Our strategic priorities are progressing and we are strengthening our capabilities, adding new capacity, and boosting R&D with complex products and key partnerships,' said Srinivas Sadu, executive chairman, Gland Pharma. 'By enhancing our base business, investing in differentiated products and driving operational efficiencies, we are positioning ourselves for sustained growth. Our focus on adherence to global quality standards and investment in capability building position us to scale further, tap new markets and deliver long-term value,' said Shyamakant Giri, chief executive officer, Gland Pharma. During the quarter, research and development (R&D) expenses stood at ₹46 crore, accounting for 4.4 per cent of revenue. The company launched 12 new molecules in regulated markets, including Colistimethate, Epinephrine, Vancomycin (three new strengths), Liraglutide and Acetaminophen bags. One abbreviated new drug application (ANDA) was filed and nine were approved during the quarter, bringing cumulative US ANDA filings to 372 (325 approved and 47 pending). Its in-house complex pipeline saw six product launches, with three more awaiting approval. Complex injectables remain a key driver of long-term growth, with more products being added to the pipeline. Fifteen products are in co-development (seven under the 505(b)(2) pathway and eight ANDAs), with commercialisation expected to begin in FY28. One ready-to-use (RTU) infusion bag was filed this quarter, bringing the total RTU product filings in the US to 20 (14 approved). Another 10 are in development, targeting a $767 million market. The company expanded its GLP-1 portfolio, launching Liraglutide in the UK and Australia, and is increasing GLP-1/pen/cartridge capacity from 40 million to 140 million units. It also received a good manufacturing practice (GMP) compliance certificate from the Danish Medicines Agency for aseptically prepared powder for injection, infusion and inhalation. The results were announced after market hours. Gland Pharma's stock fell by 0.95 per cent, ending the day's trade at ₹1,962.30 per share on the BSE.
